Amgen Inc. (FRA:AMG)
254.00
-6.15 (-2.36%)
At close: Oct 23, 2025
Amgen Revenue
Amgen had revenue of $9.18B USD in the quarter ending June 30, 2025, with 9.43% growth. This brings the company's revenue in the last twelve months to $34.92B, up 12.88% year-over-year. In the year 2024, Amgen had annual revenue of $33.42B with 18.57% growth.
Revenue (ttm)
$34.92B
Revenue Growth
+12.88%
P/S Ratio
4.62
Revenue / Employee
$1.25M
Employees
28,000
Market Cap
137.23B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
| Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
| Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
| Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
| Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 139.36B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Aktiengesellschaft | 78.30B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Siemens Energy AG | 38.39B |
| SAP SE | 36.49B |
| Deutsche Bank Aktiengesellschaft | 30.07B |
Amgen News
- 10 hours ago - Top Research Reports for Amazon.com, Wells Fargo & Amgen - Nasdaq
- 16 hours ago - These low-risk stocks could be a profitable answer to this volatile earnings season - Market Watch
- 1 day ago - Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 1 day ago - See Which Of The Latest 13F Filers Holds AMGN - Nasdaq
- 2 days ago - AstraZeneca And Amgen's Tezspire Approved In EU For Severe Nasal Polyps - Nasdaq
- 3 days ago - Notable Monday Option Activity: AMGN, ISRG, EXEL - Nasdaq
- 6 days ago - Amgen And AstraZeneca's TEZSPIRE Approved For Epithelial-Driven Nasal Inflammation - Nasdaq
- 6 days ago - FDA Approves New Use for Amgen's (AMGN) Tezspire - GuruFocus